International Biotechnology (UK) Today
| IBT Stock | 706.00 4.00 0.56% |
PerformanceModest
| Odds Of DistressVery Small
|
International Biotechnology is trading at 706.00 as of the 16th of February 2025, a 0.56 percent decrease since the beginning of the trading day. The stock's lowest day price was 706.0. International Biotechnology has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 17th of January 2025 and ending today, the 16th of February 2025. Click here to learn more.
Business Domain Financial Services | Category Healthcare | Classification Financials |
International Biotechnology is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 35.66 M outstanding shares. More on International Biotechnology Trust
Moving against International Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
International Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. International Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding International Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, International Biotechnology's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to International Biotechnology's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Asset Management & Custody Banks, Financial Services, Financials, Biotech, Computers, Financials, Capital Markets, Asset Management, Financial Services, Computing (View all Sectors) | ||||
International Biotechnology's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to International Biotechnology's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsInternational Biotechnology can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand International Biotechnology's financial leverage. It provides some insight into what part of International Biotechnology's total assets is financed by creditors.
| |||||
International Biotechnology Trust (IBT) is traded on London Exchange in UK and employs 7 people. International Biotechnology is listed under Asset Management & Custody Banks category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 251.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate International Biotechnology's market, we take the total number of its shares issued and multiply it by International Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. International Biotechnology operates under Capital Markets sector and is part of Financials industry. The entity has 35.66 M outstanding shares.
International Biotechnology generates positive cash flow from operations, but has no cash available
Check International Biotechnology Probability Of Bankruptcy
Ownership AllocationInternational Biotechnology Trust has a total of 35.66 Million outstanding shares. Roughly 72.28 (percent) of International Biotechnology outstanding shares are held by general public with 1.39 % owned by insiders and only 26.33 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check International Ownership Details
International Biotechnology Risk Profiles
Although International Biotechnology's alpha and beta are two of the key measurements used to evaluate International Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.836 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.59 | |||
| Risk Adjusted Performance | (0.01) |
International Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in International Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
International Biotechnology Corporate Management
Elected by the shareholders, the International Biotechnology's board of directors comprises two types of representatives: International Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of International. The board's role is to monitor International Biotechnology's management team and ensure that shareholders' interests are well served. International Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, International Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ailsa Craig | Investment Mang | Profile | |
| CEFA MD | Lead Manager | Profile | |
| Catherine MBA | Managing Partner | Profile | |
| Claire Jackson | Company Secretary | Profile | |
| Marek Eng | Investment Mang | Profile | |
| Carl Janson | Lead Manager | Profile | |
| Lucy Duarte | Head Relations | Profile |
Other Information on Investing in International Stock
International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.